{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:08:58Z","timestamp":1790024938107,"version":"4.0.1"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T00:00:00Z","timestamp":1627603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Age-related comorbidities prone older adults to polypharmacy and to an increased risk of potentially inappropriate medication (PIM) use. This work aims to analyze the concordance and overlap among the EU(7)-PIM list, 2019 Beers criteria, and Screening Tool of Older Person\u2019s Prescriptions (STOPP) version 2 criteria and also to analyze the prevalence of PIM.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> A retrospective cohort study was conducted on older inpatients of an internal medicine ward. Demographic, clinical, and pharmacological data were collected, during March 2020. After PIM identification by the EU(7)-PIM list, Beers criteria, and STOPP v2 criteria, the concordance and overlap between criteria were analyzed. A descriptive analysis was performed, and all the results with a <jats:italic>p<\/jats:italic>-value lower than 0.05 were considered statistically significant.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> A total of 616 older patients were included in the study whose median age was 85 (Q1\u2013Q3) (78\u201389) years. Most of the older patients were male (51.6%), and the median (Q1\u2013Q3) number of days of hospitalization was 17 (13\u201322) days. According to the EU(7)-PIM list, Beers criteria, and STOPP criteria, 79.7, 92.0, and 76.5% of older adults, respectively, used at least one PIM. A poor concordance (&amp;lt;63.4%) among criteria was observed. An association between PIM and the number of prescribed medicines was found in all applied criteria. Moreover, an association between the number of PIMs and diagnoses of endocrine, nutritional, and metabolic diseases, mental, behavioral, and neurodevelopmental disorders, and circulatory system diseases and days of hospitalization was observed according to Beers criteria, and that with diseases of the circulatory system and musculoskeletal system and connective tissue was observed according to STOPP criteria.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Despite the poor concordance between the EU(7)-PIM list, 2019 Beers, and STOPP v2 criteria, this work highlights the need for more studies in inpatients to develop strategies to facilitate the identification of PIM to decrease the high prevalence of PIM in hospitalized patients. The poor concordance among criteria also highlights the need to develop new tools adapting the existing criteria to medical ward inpatients.<\/jats:p>","DOI":"10.3389\/fphar.2021.676020","type":"journal-article","created":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T04:53:57Z","timestamp":1627620837000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":42,"title":["Prescription of Potentially Inappropriate Medication in Older Inpatients of an Internal Medicine Ward: Concordance and Overlap Among the EU(7)-PIM List and Beers and STOPP Criteria"],"prefix":"10.3389","volume":"12","author":[{"given":"Carla","family":"Perp\u00e9tuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana I.","family":"Pl\u00e1cido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Aperta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Pi\u00f1eiro-Lamas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolfo","family":"Figueiras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Herdeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1tima","family":"Roque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.anclin.2015.05.003","article-title":"Physiology Considerations in Geriatric Patients","volume":"33","author":"Alvis","year":"2015","journal-title":"Anesthesiology Clin."},{"key":"B2","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1111\/jcpt.12733","article-title":"Prevention of Potentially Inappropriate Medication in Internal Medicine Patients: A Prospective Study Using the Electronic Application PIM-Check","volume":"43","author":"Blanc","year":"","journal-title":"J. Clin. Pharm. Ther."},{"key":"B3","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/jcpt.12638","article-title":"A Comparison of Two Tools to Screen Potentially Inappropriate Medication in Internal Medicine Patients","volume":"43","author":"Blanc","year":"","journal-title":"J. Clin. Pharm. Ther."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1007\/s00228-019-02722-0","article-title":"2015 Beers Criteria and STOPP V2 for Detecting Potentially Inappropriate Medication in Community-Dwelling Older People: Prevalence, Profile, and Risk Factors","volume":"75","author":"Blanco-Reina","year":"2019","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.sapharm.2018.11.007","article-title":"Older Adults Using Multi-Dose Dispensing Exposed to Risks of Potentially Inappropriate Medications","volume":"15","author":"Bobrova","year":"2019","journal-title":"Res. Soc. Administrative Pharm."},{"key":"B6","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/jgs.15767","article-title":"American Geriatrics Society 2019 Updated AGS Beers Criteria\u00ae for Potentially Inappropriate Medication Use in Older Adults","volume":"67","author":"By the American Geriatrics Society Beers Criteria\u00ae Update Expert Panel","year":"2019","journal-title":"J. Am. Geriatr. Soc."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1007\/s11096-019-00920-5","article-title":"Patients' Clinical Information Requirements to Apply the STOPP\/START Criteria","volume":"41","author":"Carvalho","year":"2019","journal-title":"Int. J. Clin. Pharm."},{"key":"B8","doi-asserted-by":"publisher","first-page":"947","DOI":"10.2165\/11584850-000000000-00000","article-title":"Comparison of Published Explicit Criteria for Potentially Inappropriate Medications in Older Adults","volume":"27","author":"Chang","year":"2010","journal-title":"Drugs & Aging"},{"key":"B9","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s12553-020-00419-4","article-title":"The Potential to Quantify Polypharmacy in Older Adult Hospital Inpatients Using Electronic Prescribing Software: a Feasibility Study","volume":"10","author":"Connor","year":"2020","journal-title":"Health Technol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"545","DOI":"10.2165\/00002018-200831060-00009","article-title":"Prevalence, Clinical Features and Avoidability of Adverse Drug Reactions as Cause of Admission to a Geriatric Unit","volume":"31","author":"Franceschi","year":"2008","journal-title":"Drug Saf."},{"key":"B11","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/ageing\/afn197","article-title":"STOPP (Screening Tool of Older Persons' Potentially Inappropriate Prescriptions): Application to Acutely Ill Elderly Patients and Comparison with Beers' Criteria","volume":"37","author":"Gallagher","year":"2008","journal-title":"Age and Ageing"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1017\/s1041610217002411","article-title":"Polimedication: Applicability of a Computer Tool to Reduce Polypharmacy in Nursing Homes","volume":"30","author":"Garc\u00eda-Caballero","year":"2018","journal-title":"Int. Psychogeriatr."},{"key":"B13","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3389\/fphar.2018.00350","article-title":"Adverse Drug Reactions in Hospitalized Patients: Results of the FORWARD (Facilitation of Reporting in Hospital Ward) Study","volume":"9","author":"Giardina","year":"2018","journal-title":"Front. Pharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/jcpt.12494","article-title":"The Use of Potentially Inappropriate Medications Among the Lithuanian Elderly According to Beers and EU(7)-PIM List - a Nationwide Cross-Sectional Study on Reimbursement Claims Data","volume":"42","author":"Grina","year":"2017","journal-title":"J. Clin. Pharm. Ther."},{"key":"B15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.rceng.2016.01.004","article-title":"Interventions to Optimize Pharmacologic Treatment in Hospitalized Older Adults: a Systematic Review","volume":"216","author":"Gutierrez Valencia","year":"2016","journal-title":"Revista Clinica Espanola"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1001\/archinternmed.2011.215","article-title":"Potentially Inappropriate Medications Defined by STOPP Criteria and the Risk of Adverse Drug Events in Older Hospitalized Patients","volume":"171","author":"Hamilton","year":"2011","journal-title":"Arch. Intern. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"CD009783","DOI":"10.1002\/14651858.CD009783.pub2","article-title":"Interventions for Preventing Intensive Care Unit Delirium in Adults","volume":"11","author":"Herling","year":"","journal-title":"Cochrane Database Syst. Rev."},{"key":"B18","doi-asserted-by":"publisher","first-page":"CD009783","DOI":"10.1002\/14651858.CD009783.pub2","article-title":"Interventions for Preventing Intensive Care Unit Delirium in Adults","volume":"11","author":"Herling","year":"","journal-title":"Cochrane Database Syst. Rev."},{"key":"B19","doi-asserted-by":"publisher","first-page":"373","DOI":"10.5694\/mja13.00172.PMID.25877120","article-title":"Polypharmacy Among Inpatients Aged 70 Years or Older in Australia","volume":"202","author":"Hubbard","year":"2015","journal-title":"Med. J. Aust."},{"key":"B20","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/jep.12521","article-title":"Prevalence and Factors Associated with Potentially Inappropriate Prescriptions Among Older Patients at Hospital Discharge","volume":"22","author":"Hudhra","year":"2016","journal-title":"J. Eval. Clin. Pract."},{"key":"B21","volume-title":"Proje\u00e7\u00f5es de Popula\u00e7\u00e3o Residente em Portugal","year":"2017"},{"key":"B22","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/jgs.15138","article-title":"Inappropriate Prescribing in Older Hospitalized Adults: A Comparison of Medical Specialties","volume":"66","author":"Juliano","year":"2018","journal-title":"J. Am. Geriatr. Soc."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00228-013-1575-8","article-title":"Inappropriate Prescribing: a Systematic Overview of Published Assessment Tools","volume":"70","author":"Kaufmann","year":"2014","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.therap.2018.10.006","article-title":"Pharmacoepidemiology in Older People: Purposes and Future Directions","volume":"74","author":"Laroche","year":"2019","journal-title":"Therapies"},{"key":"B25","doi-asserted-by":"publisher","first-page":"18212","DOI":"10.7812\/TPP\/18.212","article-title":"Refining the Definition of Polypharmacy and its Link to Disability in Older Adults: Conceptualizing Necessary Polypharmacy, Unnecessary Polypharmacy, and Polypharmacy of Unclear Benefit","volume":"24","author":"Lee","year":"2020","journal-title":"Perm J."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e0219898","DOI":"10.1371\/journal.pone.0219898","article-title":"Inappropriate Prescribing Defined by STOPP and START Criteria and its Association with Adverse Drug Events Among Hospitalized Older Patients : A Multicentre , Prospective Study","volume":"14","author":"Loganathan","year":"2019","journal-title":"PLOS ONE"},{"key":"B27","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.archger.2016.09.003","article-title":"Inappropriate Prescribing in Older Persons: A Systematic Review of Medications Available in Different Criteria","volume":"68","author":"Lucchetti","year":"2017","journal-title":"Arch. Gerontol. Geriatr."},{"key":"B28","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2147\/CIA.S190983","article-title":"Comparison of Three Criteria for Potentially Inappropriate Medications in Chinese Older Adults","volume":"14","author":"Ma","year":"2019","journal-title":"Clin. Interv. Aging"},{"key":"B29","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1136\/ejhpharm-2017-001262","article-title":"Applicability of the STOPP\/START Criteria to Older Polypathological Patients in a Long-Term Care Hospital","volume":"25","author":"Martin","year":"2017","journal-title":"Eur. J. Hosp. Pharm."},{"key":"B46","first-page":"4","article-title":"Revis\u00e3o da medica\u00e7\u00e3o em idosos institucionalizados: aplica\u00e7\u00e3o dos crit\u00e9rios STOPP E START","volume-title":"Revista Portuguesa De Farmacoterapia","author":"Metelo de N\u00e1poles Periquito","year":"2014"},{"key":"B30","doi-asserted-by":"publisher","first-page":"795","DOI":"10.2147\/ppa.s247013","article-title":"Medication Evaluation in Portuguese Elderly Patients According to Beers, STOPP\/START Criteria and EU(7)-PIM List - an Exploratory Study","volume":"14","author":"Monteiro","year":"2020","journal-title":"Ppa"},{"key":"B31","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00228-018-2446-0","article-title":"Potentially Inappropriate Medication in the Elderly: a Systematic Review of Validated Explicit Criteria","volume":"74","author":"Motter","year":"2018","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.3389\/fphar.2019.01408","article-title":"Pain and Inflammation Management in Older Adults: A Brazilian Consensus of Potentially Inappropriate Medication and Their Alternative Therapies","volume":"10","author":"Motter","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s00228-017-2246-y","article-title":"Potentially Inappropriate Medicines in Elderly Hospitalised Patients According to the EU(7)-PIM List, STOPP Version 2 Criteria and Comprehensive Protocol","volume":"73","author":"Mucalo","year":"2017","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"806e1","DOI":"10.1016\/j.jamda.2017.06.005","article-title":"Determinants of Potentially Inappropriate Medication Use in Long-Term and Acute Care Settings: A Systematic Review","volume":"18","author":"Nothelle","year":"2017","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1111\/ggi.12944","article-title":"Comparison of Four Criteria for Potentially Inappropriate Medications in Brazilian Community-Dwelling Older Adults","volume":"17","author":"Novaes","year":"2017","journal-title":"Geriatr. Gerontol. Int."},{"key":"B36","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/ageing\/afu145","article-title":"STOPP\/START Criteria for Potentially Inappropriate Prescribing in Older People: Version 2","volume":"44","author":"O'mahony","year":"2015","journal-title":"Age Ageing"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1111\/bcp.14685","article-title":"Trends in Polypharmacy and Potentially Inappropriate Medication (PIM) in Older and Middle-Aged People Treated for Diabetes","volume":"87","author":"Oktora","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"CD009377","DOI":"10.1002\/14651858.cd009377.pub3","article-title":"Haloperidol for Psychosis\u2010induced Aggression or Agitation (Rapid Tranquillisation)","volume":"7","author":"Ostinelli","year":"2017","journal-title":"Cochrane database Syst. Rev."},{"key":"B39","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2147\/cia.s9564","article-title":"Inappropriate Prescribing in the Hospitalized Elderly Patient: Defining the Problem, Evaluation Tools, and Possible Solutions","volume":"5","author":"Page","year":"2010","journal-title":"Clin. Interv. Aging"},{"key":"B40","volume-title":"RE: PORDATA - Base de Dados Portugal Contempor\u00e2neo- Popula\u00e7\u00e3o residente: total e por grandes grupos et\u00e1rios","year":"2020"},{"key":"B41","doi-asserted-by":"publisher","first-page":"303","DOI":"10.7861\/clinmedicine.6-3-303","article-title":"The Prevention, Diagnosis and Management of Delirium in Older People: Concise Guidelines","volume":"6","author":"Potter","year":"2006","journal-title":"Clin. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s00228-015-1860-9","article-title":"The EU(7)-PIM List: a List of Potentially Inappropriate Medications for Older People Consented by Experts from Seven European Countries","volume":"71","author":"Renom-Guiteras","year":"2015","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/jhm.290","article-title":"Potentially Inappropriate Medication Use in Hospitalized Elders","volume":"3","author":"Rothberg","year":"2008","journal-title":"J. Hosp. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/14740338.2018.1415322","article-title":"German Net of Regional Pharmacovigilance, C.Preventable ADRs Leading to Hospitalization - Results of a Long-Term Prospective Safety Study with 6,427 ADR Cases Focusing on Elderly Patients","volume":"17","author":"Schmiedl","year":"2018","journal-title":"Expert Opin. Drug Saf."},{"key":"B45","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/1471-2318-14-96","article-title":"Efficacy and Safety of Haloperidol Prophylaxis for Delirium Prevention in Older Medical and Surgical At-Risk Patients Acutely Admitted to Hospital through the Emergency Department: Study Protocol of a Multicenter, Randomised, Double-Blind, Placebo-Controlled Clinical Trial","volume":"14","author":"Schrijver","year":"2014","journal-title":"BMC Geriatr."},{"key":"B47","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.jamda.2013.02.021","article-title":"Medication Reconciliation in Continuum of Care Transitions: a Moving Target","volume":"14","author":"Sinvani","year":"2013","journal-title":"J. Am. Med. Directors Assoc."},{"key":"B48","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.arr.2010.04.005","article-title":"Geriatric Drug Therapy: Neglecting the Inevitable Majority","volume":"9","author":"Stegemann","year":"2010","journal-title":"Ageing Res. Rev."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1111\/j.1532-5415.2006.00889.x","article-title":"Polypharmacy and Prescribing Quality in Older People","volume":"54","author":"Steinman","year":"2006","journal-title":"J. Am. Geriatr. Soc."},{"key":"B50","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/jjco\/hyu220","article-title":"Methodological Issues in Observational Studies and Non-randomized Controlled Trials in Oncology in the Era of Big Data","volume":"45","author":"Tanaka","year":"2015","journal-title":"Jpn. J. Clin. Oncol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3390\/geriatrics5020037","article-title":"Potentially Inappropriate Prescribing and Potential Prescribing Omissions in 82,935 Older Hospitalised Adults: Association with Hospital Readmission and Mortality within Six Months","volume":"5","author":"Thomas","year":"2020","journal-title":"Geriatrics"},{"key":"B52","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2174\/1874609812666190516093742.PMID.31096900","article-title":"A Systematic Review of Studies of the STOPP\/START 2015 and American Geriatric Society Beers 2015 Criteria in Patients \u2265 65 Years","volume":"12","author":"Thomas","year":"2019","journal-title":"Cas"},{"key":"B53","doi-asserted-by":"publisher","first-page":"e0166359","DOI":"10.1371\/journal.pone.0166359","article-title":"Intervention to Improve Appropriate Prescribing and Reduce Polypharmacy in Elderly Patients Admitted to an Internal Medicine Unit","volume":"11","author":"Urfer","year":"2016","journal-title":"PLoS One"},{"key":"B54","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.ejim.2007.12.002","article-title":"Prevalence of Drug-Drug Interactions at Hospital Entry and during Hospital Stay of Patients in Internal Medicine","volume":"19","author":"Vonbach","year":"2008","journal-title":"Eur. J. Intern. Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s11096-019-00847-x","article-title":"Assessment of Potentially Inappropriate Medications Using the EU ( 7 )- PIM List and the Swedish Quality Indicators","volume":"41","author":"Wamil","year":"2019","journal-title":"Int. J. Clin. Pharm."},{"key":"B56","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology2021"},{"key":"B57","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s40801-016-0085-2","article-title":"Potentially Inappropriate Medication Use in Multimorbid Elderly Inpatients: Differences between the FORTA, PRISCUS and STOPP Ratings","volume":"3","author":"Wickop","year":"2016","journal-title":"Drugs - Real World Outcomes"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2020.00326","article-title":"An Increasing Trend in the Prevalence of Polypharmacy in Sweden: A Nationwide Register-Based Study","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Pharmacol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.676020\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T04:54:04Z","timestamp":1627620844000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.676020\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,30]]},"references-count":58,"alternative-id":["10.3389\/fphar.2021.676020"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2021.676020","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,30]]},"article-number":"676020"}}